Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 136 (RN7SKP136) is a human pseudogene related to the functional 7SK small nuclear RNA (RN7SK), which is a key component of the 7SK ribonucleoprotein (snRNP) complex involved in the regulation of transcription elongation by RNA polymerase II[2][3]. As a pseudogene, RN7SKP136 is a genomic DNA sequence similar to RN7SK but is generally regarded as non-functional because it is not expected to be actively transcribed or translated into a functional product[2]. The parental, functional RN7SK RNA plays an essential role in regulating the positive transcription elongation factor P-TEFb and, by extension, transcriptional pausing and control in higher eukaryotes[1]. However, there is currently no evidence that RN7SKP136 itself has any known biological function, disease association, or relevance as a drug target[2]. It is not recognized as a receptor, enzyme, transporter, or other established therapeutic target, nor are there any known drugs or safety concerns related to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 136 (RN7SKP136).